IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.330
EU - Europa 3.530
AS - Asia 2.736
SA - Sud America 268
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 11.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.286
SG - Singapore 1.296
CN - Cina 807
IE - Irlanda 769
UA - Ucraina 616
SE - Svezia 524
IT - Italia 446
TR - Turchia 410
GB - Regno Unito 277
DE - Germania 249
BR - Brasile 245
FR - Francia 181
FI - Finlandia 172
RU - Federazione Russa 145
IN - India 68
AT - Austria 37
VN - Vietnam 31
CA - Canada 30
HK - Hong Kong 27
BE - Belgio 25
TW - Taiwan 23
NL - Olanda 22
ES - Italia 21
CZ - Repubblica Ceca 13
EU - Europa 12
AU - Australia 10
JP - Giappone 9
AR - Argentina 7
IL - Israele 7
IR - Iran 7
MX - Messico 7
EC - Ecuador 6
KR - Corea 6
MA - Marocco 6
PL - Polonia 6
TH - Thailandia 6
ZA - Sudafrica 6
ID - Indonesia 5
KE - Kenya 5
RO - Romania 5
BD - Bangladesh 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
JM - Giamaica 3
LT - Lituania 3
NO - Norvegia 3
PK - Pakistan 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CO - Colombia 2
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
IQ - Iraq 2
JO - Giordania 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
SR - Suriname 2
TN - Tunisia 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
VE - Venezuela 1
Totale 11.917
Salva come PNG Salva come JPEG
Città #
Chandler 1.002
Jacksonville 864
Singapore 864
Dublin 758
Princeton 393
Izmir 271
Ashburn 229
Nanjing 214
Altamura 184
Southend 177
Wilmington 168
Santa Clara 147
Cambridge 137
Dearborn 132
Beijing 126
The Dalles 118
Boardman 90
Ann Arbor 83
Nanchang 71
Woodbridge 68
Los Angeles 65
Helsinki 62
Chieti 61
Houston 59
Hebei 46
Kunming 46
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Seattle 32
Dong Ket 31
Nuremberg 26
Pescara 26
Vienna 26
Changsha 25
Hong Kong 25
New York 25
Brussels 23
Norwalk 22
São Paulo 22
Munich 20
Guangzhou 17
Hangzhou 17
Fairfield 14
Falls Church 13
Leawood 13
Pune 13
Taipei 12
Grevenbroich 11
Olomouc 11
Chicago 10
Hefei 10
San Mateo 10
Edinburgh 9
London 9
Shanghai 9
Changchun 8
Jinan 8
Madrid 8
Montreal 8
Rome 8
Romola 8
San Francisco 8
Sydney 8
Ardabil 7
Hanover 7
Moscow 7
Orange 7
Amsterdam 6
Augusta 6
Bangkok 6
Milan 6
Mountain View 6
Stockholm 6
Suresnes 6
Teramo 6
Tokyo 6
Turku 6
Warsaw 6
Atlanta 5
Belo Horizonte 5
Brooklyn 5
Cheyenne 5
Frankfurt am Main 5
Mumbai 5
Nairobi 5
Redwood City 5
Rochester 5
Saint Louis 5
Toronto 5
Zhengzhou 5
Auburn Hills 4
Boston 4
Charlotte 4
Chennai 4
Clifton 4
Des Moines 4
Florence 4
Istanbul 4
Totale 7.308
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 208
Supportive management strategies for disseminated intravascular coagulation: An international consensus 136
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 124
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 120
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 108
Treatment of Lower Extremity Superficial Thrombophlebitis 102
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 95
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 92
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 92
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 92
Circulating leptin is associated with oxidized LDL in postmenopausal women. 91
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 91
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 88
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 86
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 86
The hematocrit and platelet target in polycytemia vera 85
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 85
Antithrombotic therapy and cancer 85
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 85
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 85
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 84
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 84
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 82
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 82
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 82
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 82
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 81
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 81
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 80
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 80
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 80
Non-O blood group and outcomes of in vitro fertilization 80
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 79
Rivaroxaban for cancer-associated cardiac thrombosis 78
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 78
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 77
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 76
Effects of body composition on the procoagulant imbalance in obese patients 76
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 75
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 75
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 75
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 74
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 74
Improving the diagnostic management of upper extremity deep vein thrombosis 74
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 74
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 74
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 73
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 73
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 73
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 72
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 72
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 72
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 72
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 71
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 71
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 71
Edoxaban for the treatment of cancer-associated venous thromboembolism 71
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 71
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 70
The SISET incorrectly cited the JAAM DIC scoring system 70
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 70
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 70
D-Dimer test in cancer patients with suspected acute pulmonary embolism 70
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 69
Decision analysis for cancer screening in idiopathic venous thromboembolism 69
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 69
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 69
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 69
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 69
Cell-derived microvesicles and cancer 68
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 68
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 68
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 68
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 68
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 68
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 67
Treatment for superficial infusion thrombophlebitis of the upper extremity. 67
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 67
Cannabinoids for medical use: A systematic review and meta-analysis 66
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 66
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 66
Pravastatin-dependent TGF-β1 effect on scavenger receptor class A expression in THP-1 human macrophages 66
Deep vein thrombosis and pulmonary embolism 65
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: A systematic review 65
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 65
Splanchnic vein thrombosis: Current perspectives 65
Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 64
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 64
Cancer-associated unsuspected pulmonary embolism 64
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 64
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 64
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: Guidance from the SSC of the ISTH 64
Low molecular-weight heparins improve the survival of cancer patients? 63
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer 63
Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? 63
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis 63
Inhaled analgesia for pain management in labour 63
Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists 62
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment 62
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 62
Totale 7.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021980 127 20 278 27 72 228 10 9 12 68 50 79
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.883 200 619 402 63 52 98 76 250 345 130 353 295
Totale 12.622